tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ENLV Stock Latest News

Enlivex Therapeutics Launches Knee Osteoarthritis Trial
Company AnnouncementsEnlivex Therapeutics Launches Knee Osteoarthritis Trial
3d ago
6K
ENLV
Enlivex announces dosing of first two patients in trail on Allocetra
PremiumThe Fly
Enlivex announces dosing of first two patients in trail on Allocetra
3d ago
ENLV
Enlivex Advances Osteoarthritis Trial in Denmark
PremiumCompany Announcements
Enlivex Advances Osteoarthritis Trial in Denmark
9d ago
6K
ENLV
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
PremiumPress Releases
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
9d ago
ENLV
Enlivex announces DKMA authorization for Phase I/II trial of allocetra
PremiumThe Fly
Enlivex announces DKMA authorization for Phase I/II trial of allocetra
9d ago
ENLV
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
PremiumPress ReleasesEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
14d ago
ENLV
Enlivex’s Allocetra™ Shows Promise in Sepsis Trial
PremiumCompany Announcements
Enlivex’s Allocetra™ Shows Promise in Sepsis Trial
14d ago
6K
ENLV
Enlivex Therapeutics announces results of its Phase II trial of Allocetra
PremiumThe Fly
Enlivex Therapeutics announces results of its Phase II trial of Allocetra
14d ago
ENLV
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
PremiumPress Releases
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
14d ago
ENLV
Enlivex Therapeutics’ Stable Financial Outlook
PremiumCompany Announcements
Enlivex Therapeutics’ Stable Financial Outlook
27d ago
6K
ENLV
Enlivex Therapeutics issued U.S. patent covering Allocetra cells
PremiumThe Fly
Enlivex Therapeutics issued U.S. patent covering Allocetra cells
3M ago
ENLV
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
PremiumPress Releases
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
3M ago
ENLV
Enlivex Therapeutics receives IMOH regulatory authorization
PremiumThe FlyEnlivex Therapeutics receives IMOH regulatory authorization
3M ago
ENLV
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
NGM
NVS
Enlivex Therapeutics completes enrollment in Phase II trial of Allocetra
PremiumThe Fly
Enlivex Therapeutics completes enrollment in Phase II trial of Allocetra
4M ago
ENLV
MediWound appoints Hess as Chief Operating Officer, Chief Commercial Officer
PremiumThe Fly
MediWound appoints Hess as Chief Operating Officer, Chief Commercial Officer
5M ago
ENLV
MDWD
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
AUTL
CYTO
Enlivex Therapeutics price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe Fly
Enlivex Therapeutics price target lowered to $12 from $15 at H.C. Wainwright
7M ago
ENLV
Enlivex Therapeutics to reduce workforce by 50%
PremiumThe Fly
Enlivex Therapeutics to reduce workforce by 50%
8M ago
ENLV
Enlivex Therapeutics announces reprioritization plan
PremiumThe FlyEnlivex Therapeutics announces reprioritization plan
8M ago
ENLV
Enlivex Therapeutics expects cash to fund operations through end of 2025
PremiumThe Fly
Enlivex Therapeutics expects cash to fund operations through end of 2025
8M ago
ENLV
Enlivex Therapeutics announces peer-reviewed publication on Allocetra
PremiumThe Fly
Enlivex Therapeutics announces peer-reviewed publication on Allocetra
9M ago
ENLV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >